Open AccessEffects of γ-Aminobutyric Acid–Modulating Drugs on Working Memory and Brain Function in Patients With Schizophrenia
Author(s) -
Lara Menzies,
Cinly Ooi,
Shri Kamath,
John Suckling,
Peter J. McKenna,
Paul C. Fletcher,
Edward T. Bullmore,
C. Stephenson
Publication year - 2007
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.64.2.156
Subject(s) - lorazepam , flumazenil , psychology , working memory , schizophrenia (object oriented programming) , functional magnetic resonance imaging , neuroscience , medicine , anesthesia , psychiatry , cognition , benzodiazepine , receptor
Cognitive impairment causes morbidity in schizophrenia and could be due to abnormalities of cortical interneurons using the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom